Overview

Carbetocin Versus Oxytocin and Hemodynamic Effects

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
A randomized double-blind trial of oxytocin 5 u, carbetocin 100 µg and placebo with hemodynamic response as a primary outcome measure.
Phase:
Phase 4
Details
Lead Sponsor:
Oslo University Hospital
Treatments:
Carbetocin
Oxytocin